Morepen Laboratories Launches ‘Dr. Morepen Sync’ Mobile App for Real-Time Health Monitoring

images-5.webp
Gurugram, January 28, 2025Morepen Laboratories Limited (NSE: MOREPENLAB, BSE: 500288) has launched its Dr. Morepen Sync Mobile App, designed to enhance real-time health monitoring for diabetes, hypertension, and obesity management. The app was introduced as a Republic Day initiative to empowerindividuals to track their health metrics seamlessly.

Key Features of Dr. Morepen Sync App

  • Effortless Health Monitoring: Users can log and track key health indicators such as blood glucose, blood pressure, and weight using multiple input methods – manual entry, scanning, voice command, or photo capture.
  • Historical Data & Insights: The app provides detailed reports with trends and visual insights, helping users analyze their health progress over time.
  • Custom Reminders & Alerts: Personalized notifications ensure that users never miss check-ups or medication schedules.
  • Doctor-Friendly Reports: The app allows users to generate and share detailed health reports with doctors and caregivers for better consultation.
  • Integration with Morepen Diagnostic Devices: The app is fully compatible with Morepen's medical devices, ensuring accurate and real-time health tracking.

Industry Need & Health Impact

With over 50% of diabetes cases undiagnosed in India and rising stress-induced hypertension and obesity rates, the Dr. Morepen Sync Mobile App is positioned as a critical tool for preventive healthcare and chronic disease management.
Anubhav Suri, CEO of Medical Devices, Dr. Morepen, stated:
"At Dr. Morepen, we believe in making healthcare accessible and user-friendly. The Dr. Morepen Sync App is more than just a tool—it's a digital companion that encourages people to take control of their health. Together, let's 'Get Set Sync'and move toward a healthier, happier future."

Market Position & Morepen's Expansion Strategy

Morepen Laboratories has:
  • Installed over 13.65 million glucometers across India.
  • Sold 1.86 billion glucose strips, solidifying its leadership in home diagnostics.
  • Expanded into Tier-2 and Tier-3 markets, bridging healthcare accessibility gaps.

About Morepen Laboratories

Founded in 1984, Morepen Laboratories is a leading player in the pharmaceutical and medical devices industry. Its expertise is in Active Pharmaceutical Ingredients (APIs) and Point-of-Care diagnostics. The company exports to multiple international markets and holds a leadership position in API exports for Loratadine, Montelukast, Desloratadine, Atorvastatin, and Fexofenadine.

Strategic Outlook

The launch of Dr. Morepen Sync aligns with Morepen's digital healthcare expansion strategy, focusing on preventive healthcare, early detection, and AI-driven insights for patient management.
 
Back
Top